Showing results (121-130 of 218) with videos related to
Sort By:
Pageof 22
Nature|June 16, 1983
Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibodyJ W Forstrom, K A Nelson, G T Nepom, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1981
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissuesJ P Brown, R G Woodbury, C E Hart, et al.Transactions. Section on Otolaryngology. American Academy of Ophthalmology and Otolaryngology|March 1, 1977
Studies on immunity to mouse sarcomas using the tumor-cell neutralization testH C Thomas, K E Hellström, M A Kall, et al.Journal of Reproductive Immunology|March 1, 1989
A monoclonal antibody, MA21, recognizes a surface component that is present on F9 teratocarcinoma cells and that appears vectorially on the trophectoderm of peri-implantation-stage mouse blastocystsR B Vernon, P A Linnemeyer, M S HamiltonBiology of Reproduction|April 1, 1985
Effects of in vivo and in vitro fertilization environments on the expression of a surface antigen of the mouse sperm tailR B Vernon, M S Hamilton, E M EddyNeurosurgery|March 17, 2000
Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft modelL G Remsen, P A Trail, I Hellström, et al.Cellular Immunology|January 1, 1987
Tumor-specific idiotopes on suppressor factors and suppressor cells revealed by monoclonal anti-idiotope antibodiesV K Kuchroo, V K Lee, I Hellström, et al.Cancer Research|October 23, 1997
Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent ratsH O Sjögren, M Isaksson, D Willner, et al.Journal of Molecular Biology|January 7, 1994
Crystallization and preliminary X-ray analysis of the monoclonal anti-tumor antibody BR96 and its complex with the Lewis Y determinantC Y Chang, P D Jeffrey, J Bajorath, et al.The Journal of Experimental Medicine|February 1, 1994
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunityL Chen, P McGowan, S Ashe, et al.Pageof 22